Clinical Trial Update: Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 study evaluating dronedarone in patients with paroxysmal atrial fibrillation who have pacemakers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Eastbourne General Hospital | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: UNKNOWN